Targeting Cell Survival Signaling for Therapeutic Discovery
1 of 3
Inhibition of the NF-κB signaling pathway by the curcumin
analogs, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31) and
3,5-Bis(2-pyridinylmethylidene)-1-methyl-4-piperidone (UBS109):
in-vitro and in-vivo studies.
2 of 3
Development of Monocarbonyl Curcumin Analogues Towards Treating
Tuberculosis and Cancer